Atrial Fibrillation and C-Reactive Protein. Searching for Local Inflammation**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 49, Issue 15, 2007, Pages 1649-1650

  Hernández Madrid, Antonio ^a   Moro, Concepción ^b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CARDIOVASCULAR DISEASE; CARDIOVERSION; CLINICAL TRIAL; COMORBIDITY; EDITORIAL; ELECTROPHYSIOLOGY; HEART ATRIUM FIBRILLATION; HEART HEMODYNAMICS; HUMAN; INFLAMMATION; META ANALYSIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; SINUS RHYTHM; SYSTEMATIC REVIEW; WEIGHT REDUCTION;

ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; PROGNOSIS; RECURRENCE; SENSITIVITY AND SPECIFICITY;

EID: 34047254482     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.02.009     Document Type: Editorial

References (14)

1. Aviles R.J., Martin D.O., Apperson-Hansen C., et al. Inflammation as a risk factor for atrial fibrillation. Circulation 108 (2003) 3006-3010
2. Frustaci A., Chimenti C., Bellocci F., Morgante E., Russo M.A., and Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96 (1997) 1180-1184
3. Engelmann M., and Hastrup Svendsen J. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 26 (2005) 2083-2092
4. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease. Application to clinical and public health practice. A statement for health-care professionals from the Center for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
5. Hernández Madrid A. Proteina C reactiva y fibrilación auricular. Un viejo marcador en busca de un nuevo sitio. Rev Esp Cardiol 59 (2006) 94-98
6. Boos C., Anderson R., and Lip G. Is atrial fibrillation an inflammatory disorder?. Eur Heart J 27 (2006) 136-149
7. Wilson P. CDC/AHA workshop on markers of inflammation and cardiovascular disease. Circulation 110 (2004) e568-e571
8. Zarauza J., Rodriguez M.J., Farinas C., et al. Relación entre niveles de proteína C reactiva y recurrencia precoz de la fibrilación auricular tras cardioversión eléctrica. Rev Esp Cardiol 59 (2006) 125-129
9. Rotter M., Jäis P., Vergnes M.C., Takahashi Y., Sanders P., Rostock T., Hocini M., et al. Decline in C-reactive protein after successful ablation of long-lasting persistent atrial fibrillation. J Am Coll Cardiol 47 (2006) 1231-1233
10. Liu T., Li G., Li L., and Korantzopoulos P. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis. J Am Coll Cardiol 49 (2007) 1642-1648
11. Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107 (2003) 363-369
12. Ellinor P.T., Low A., Patton K.K., Shea M.A., and Macrae C.A. C-reactive protein in lone atrial fibrillation. Am J Cardiol 97 (2006) 1346-1350
13. Patti G., Chello M., Candura D., et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation 114 (2006) 1455-1461
14. Lällier P.L., Ducharmen A., Keller P.F., et al. Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation. J Am Coll Cardiol 44 (2004) 159-164